XVIE to Treat Androgenetic Alopecia (AGA)
Clinical trial NCT07482423 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07482423
- Sponsor
- Restore Biologics Holdings, Inc. dba Xtressé
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2028-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.